Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Clasificación en acciones #32449
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Precio por acción
$0.04367217
Última sincronización: 2026-08-17
Capitalización bursátil
$10.06M
Cambio (1 día)
3.99%
Cambio (1 año)
-26.77%
País
SE
Comercio IDL Diagnostics AB (publ) (IDLDX)

Categoría

Historial del precio de la acción de IDL Diagnostics AB (publ) (IDLDX)
Precio más alto de cierre: $0.04 el 2026-08-01

Precio más bajo de cierre: $0.66 el 2011-05-01
Historial del precio de la acción de IDL Diagnostics AB (publ) desde 2011 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 6.57%
2025 9.67%
2024 -12.09%
2023 -20.98%
2022 -57.24%
2021 -56.70%
2020 105.13%
2019 -47.78%
2018 -46.79%
2017 -31.41%
2016 -39.64%
2015 56.69%
2014 -37.92%
2013 65.83%
2012 40.59%
2011 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$586.41 20.28%
US
$202.37 -3.18%
US
$24.22 79.42%
CN
$314.26 95.01%
US
$544.68 -14.61%
US